| CRBP Snapshot | |
|---|---|
| Corbus Pharmaceuticals Holdings, Inc., a clinical-stage pharmaceutical company, focuses on the development and commercialization of novel therapies that target the endocannabinoid system in the fields of autoimmunity, fibrosis, and cancer. The company is headquartered in Norwood, Massachusetts. | |
| VALUATION DATA | |
| Market Capitalization | $2,025 | Price to Sales | 7.00 |
| Earnings per Share | $0.0000 |
| PE Ratio | -66617000 |
| PRICE DATA | |
| Most Recent Close | $9.6600 |
| 52 Week High | $- |
| 52 Week Low | $163.32 |
| 50-Day Moving Average | $1.067 |
| 200-Day Moving Average | $8.26 |
| All data are from Alpha Vantage as of today. For more infomation on CRBP see Stock Dividend, Valuation, Price and Financial Data for Investors | |
Custom Search